Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

The new platinum complexes effectively increased survival in rats with tumors, despite some reversible side effects.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Rivaroxaban may cause hair loss.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Cepharanthine shows promise as a natural anticancer treatment.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Avacopan may cause unexpected side effects, so early monitoring is important.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Sorafenib can cause a unique skin reaction.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.